Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
LBT-3627 is under development for the treatment of Parkinson's disease. The drug candidate is administered through oral route. It is developed based on hybridtide scaffold technology. It acts by ...